What will be required to bring 68Ga-labelled peptides into routine clinical use?

Nuclear Medicine Communications

Volumn 32, Issue 12, 2011, Pages 1109-1112

  Ballinger, James R ^a   Solanki, Kishor K ^b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; EDOTREOTIDE GA 68; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; GALLIUM EDETATE GA 68; HYDROCHLORIC ACID; IGG100; ITHEMBA; LUTETIUM 177; OBNINSK; RADIOISOTOPE; RUBIDIUM 82; STRONTIUM 82; TECHNETIUM 99M; UNCLASSIFIED DRUG; YTTRIUM 90; DIAGNOSTIC AGENT; DRUG DERIVATIVE; EDOTREOTIDE; GALLIUM; OCTREOTIDE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM;

CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DRUG HALF LIFE; DRUG SYNTHESIS; HUMAN; ISOTOPE LABELING; MEDICAL LITERATURE; NEUROENDOCRINE TUMOR; POSITRON EMISSION TOMOGRAPHY; REVIEW; ROOM TEMPERATURE; SHELF LIFE; UNITED KINGDOM; COMPUTER ASSISTED EMISSION TOMOGRAPHY; EDITORIAL; LEGAL ASPECT; METHODOLOGY; PRACTICE GUIDELINE; RADIOACTIVITY; SCINTISCANNING; SYNTHESIS;

GALLIUM RADIOISOTOPES; GREAT BRITAIN; HUMANS; NEUROENDOCRINE TUMORS; OCTREOTIDE; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PRACTICE GUIDELINES AS TOPIC; RADIONUCLIDE GENERATORS; RADIOPHARMACEUTICALS; TECHNETIUM;

EID: 80455143863     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32834ae8b2     Document Type: Review

References (17)

1. Breeman WAP, Verbruggen AM. The 68Ge/68Ga generator has high potential, but when can we use 68Ga-labelled tracers in clinical routine? Eur J Nucl Med Mol Imaging 2007; 34:978-981.
2. Virgolini I, Ambrosini V, Bomanji JB, Baum RP, Fanti S, Gabriel M, et al. Procedure guidelines for PET/CT tumour imaging with 68Ga-conjugated peptides: 68Ge-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE. Eur J Nucl Med Mol Imaging 2010; 37:2004-2010.
3. Velikyan I, Beyer GJ, Langstrom B. Microwave-supported preparation of 68Ga bioconjugates with high specific radioactivity. Bioconjugate Chem 2004; 15:554-560.
4. Decristoforo C, Knopp R, von Guggenberg E, Rupprich M, Dreger T, Hess A, et al. A fully automated synthesis for the preparation of 68Ga-labelled peptides. Nucl Med Commun 2007; 28:870-875.
5. 2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides. Appl Radiat Isot 2011; 69:308-315.
6. Ballinger JR, Nawaz S, Berry DJ, Blower PJ. Monitoring the performance characteristics of the IGG100 gallium-68 generator. Nucl Med Commun 2011; 32:444.
7. Oware W, Solanki KK, Bird N, Solanki C. Quality and validation of a silicabased resin column of 68Ge/68Ga generator for use in medical product. World J Nucl Med 2011; 10:78.
8. Kosinski M, Wastiel C, Baechler S, Bochud F. Challenges of Ge-68 separation from Ga-68 eluates. World J Nucl Med 2011; 10:81.
9. Rosenfeld G. Studies of the metabolism of germanium. Arch Biochem Biophys 1954; 48:84-94.
10. Breeman WAP, de Jong M, Blois E, Bernard BF, Konijnenberg M, Krenning EP. Radiolabelling DOTA-peptides with 68Ga. Eur J Nucl Med Mol Imaging 2005; 33:478-485.
11. Zhernosekov KP, Filosofov DV, Baum RP, Aschoff P, Bihl H, Razbash AA, et al. Processing of generator-produced 68Ga for medical application. J Nucl Med 2007; 48:1741-1748.
12. Asti M, de Pietri G, Fraternali A, Grassi E, Sghedoni R, Fioroni F, et al. Validation of 68Ge/68Ga generator processing by chemical purification for routine clinical application of 68Ga-DOTATOC. Nucl Med Biol 2008; 35:721-724.
13. EudraLex. The Rules Governing Medicinal Products in the European Union, Volume 4, EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use. Annex 3: Manufacture of Radiopharmaceuticals. Brussels, 2008.
14. Berry DJ, Ma YM, Nawaz S, Ballinger JR, Tavaré R, Koers A, et al. Efficient bifunctional gallium-68 chelators for positron emission tomography: tris(hydroxypyridinone) ligands. Chem Commun 2011; 47:7068-7070.
15. Breeman WAP, de Blois E, Chan HS, Konijnenberg M, Kwekkeboom DJ, Krenning EP. 68Ga-labeled DOTA-peptides and 68Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future prospects. Semin Nucl Med 2011; 41:314-321.
16. Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 1995; 36:1301-1306.
17. Jeong JM, Hong MK, Chang YS, Lee YS, Kim YJ, Cheon GJ, et al. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice. J Nucl Med 2008; 49:830-836.